Safety and Immunogenicity of Varied Doses of R21/Matrix-M™ Vaccine at Three Years Follow-Up: A Phase 1b Age De-Escalation, Dose-Escalation Trial in Adults, Children, and Infants in Kilifi-Kenya.Samuel Sang,Mehreen S Datoo,Edward Otieno,Charles Muiruri,Duncan Bellamy, Emmaloise Gathuri,Omar Ngoto,Janet Musembi, Sam Provstgaard-Morys,Lisa Stockdale,Jeremy Aboagye, Daniel Woods,Alison Lawrie,Racheal Roberts, Kelvias Keter,Domtila Kimani,Francis Ndungu,Melissa Kapulu,Irene Njau,Benedict Orindi,Katie J Ewer,Adrian V S Hill,Philip Bejon,Mainga HamalubaWellcome open research（2023）引用 2|浏览11AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
